| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $241.6M | +2943.8% |
| R&D Expense | $152.9M | +302.4% |
| SG&A Expense | $50.6M | +65.6% |
| Operating Income | $65.6M | +347.3% |
| Interest Expense | $28.5M | +2397.5% |
| Pre-tax Income | $53.7M | +234.7% |
| Income Tax | $21.7M | — |
| Net Income | $32.1M | +178.3% |
| EPS (Basic) | -$1.35 | +49.1% |
| EPS (Diluted) | -$1.35 | +49.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20K | -99.6% |
| Inventory | $3.6M | — |
| Current Assets | $79.7M | +335.6% |
| Total Assets | $944.5M | +503.3% |
| Current Liabilities | $125.8M | +99.6% |
| Total Liabilities | $678.2M | +553.5% |
| Stockholders' Equity | $130.2M | +146.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $153.9M | +1746.4% |
| Investing Cash Flow | -$655.9M | -686.4% |
| Financing Cash Flow | $496.8M | +485.1% |